Post Market Surveillance

M2S can help transition your clinical trial from the development stage to the post-market surveillance stage. With over 10 years of experience in data and image management, M2S’ post-market registry is designed to be both flexible and scalable to ensure your needs are met. Through Clinical Data Pathways, M2S will provide the tools necessary to track your product for continuous improvement and simplify the reporting process.

 Pathways benefits include  

• Real-time tracking of post-market data 
• Expertise in image analysis and device integration 
• Early alerts for suboptimal outcomes  
• Quantifiable evidence of product or treatment’s success
• Full compliance with HIPAA and ISO regulations
  • ISO 13485:2003
  • ISO 14971:2007